期刊文献+

香菇多糖联合氟尿嘧啶体内外抗肝肿瘤作用的研究 被引量:7

In vitro and in vivo Antitumor Effect of Lentinan Combined with 5-FU
原文传递
导出
摘要 目的:研究香菇多糖与氟尿嘧啶(5-FU)的联合抗肝肿瘤作用。方法:采用MTT法检测香菇多糖联合5-FU对H22细胞增殖抑制作用;PI单染法检测细胞周期;接种H22细胞昆明小鼠为模型,进行体内抑瘤作用的考察,测定抑瘤率、脾/胸腺指数以及脾组织细胞因子白介素-2(IL-2)、白介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)浓度。结果:体外研究结果表明,香菇多糖的加入并没有进一步提高5-FU对H22细胞的抑制率,对细胞周期也没有明显的影响;体内抑瘤实验表明,香菇多糖与5-FU具有协同抑瘤作用,与单独使用5-FU比较,香菇多糖25,50 mg·kg-1联合5-FU组抑瘤率显著提高(P<0.05);香菇多糖25、50 mg·kg-1可以纠正5-FU所致的荷瘤小鼠免疫抑制作用,并能提高荷瘤小鼠脾/胸腺指数。结论:香菇多糖与5-FU具有协同抑瘤作用,其机制为非特异性免疫刺激,并非直接杀伤肿瘤细胞。 Objective:To study the in vitro and in vivo anti-tumor effect of lentinan combined with 5-FU. Methods:MTT method was used to determine the proliferation of H22 in vitro, and the cell cycle changes were analyzed by a flow cytometry. The in vivo anti-tumor effect was evaluated in Kunming mice. The tumor inhibitory rate, thymus/spleen index, IL-2, IL-6 and TNF-α were deter-mined. Results:The in vitro results revealed that lentinan had no obvious effect on the inhibitory rate and cell cycle of the cells treated with 5-FU. In vivo results showed that lentinan at the dosage of 25 and 50 mg&#183;kg-1 could obviously enhance the anti-tumor effect of 5-FU(P〈0. 05). Furthermore, lentinan could increase the thymus/spleen index of the tumor-bearing mice. Conclusion:Lentinan com-bined with 5-FU has synergistic effects on anti-tumor activity through nonspecific immune stimulation rather than the direct killing of tumor cells.
出处 《中国药师》 CAS 2015年第3期400-403,共4页 China Pharmacist
关键词 香菇多糖 氟尿嘧啶 抑瘤率 免疫刺激 协同作用 Lentinan 5-FU Tumor inhibitory rate Immune stimulation Synergistic effect
  • 相关文献

参考文献12

二级参考文献154

共引文献180

同被引文献102

  • 1张广钰,窦拉加.胃癌患者IL-10,IL-12的检测及其临床意义[J].现代肿瘤医学,2006,14(2):179-181. 被引量:8
  • 2Bilici A, Selcukbiricik F, Demir N, Oven Ustaalioglu BB, Dikilitas M, Yildiz O. Modified docetaxel and cisplatin in combination with capecitabine (DCX) as a first-line treatment in HER2-negative advanced gastric cancer. Asian Pac J Cancer Prev 2014; 15:8661-8666 [PMID: 25374186].
  • 3Oblak I, Vidmar MS, Anderluh F, Velenik V, Jeromen A, Hadzic JB. Capecitabine in adjuvant radiochemotherapy for gastric adenocarcinoma. Radiol Oncol 2014; 48:189-196 [PMID: 24991209 DOI: lO.2478/raon-2013-O065].
  • 4Grybos A, Bar J. The relationships between the immunoexpression of KAI1, MMP-2, MMP-9 and steroid receptors expression in endometrial cancer. Folia Histochem Cytobiol 2014; 52:187-194 [PMID: 25308734 DOI: 10.5603/FHC.2014.0022|.
  • 5Jung HA, Kim HJ, Maeng CH, Park SH, Lee J, Park JO, Park YS, Lim HY, Kang WK. Changes in the mean corpuscular volume after capecitabine treatment are associated with clinical response and survival in patients with advanced gastric cancer. Cancer Res Treat 2015; 47:72-77 [PMID: 25143051 DOh 10.4143/crt.2013.172].
  • 6Tepper CG, Seldin MF. Modulation of caspase-8 and FLICE-inhibitory protein expression as a potential mechanism of Epstein-Barr virus tumorigenesis in Burkitt's lymphoma. Blood 1999; 94:1727-1737 [PMID: 10477698].
  • 7Kim ST, Kang JH, Lee J, Park SH, Park JO, Park YS, Lim HY, Hwang IG, Lee SC, Park KW, Lee HR, Kang WK. Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: a double-blind randomised phase 3 study. Eur J Cancer 2014; 50:2822-2830 [PMID: 25218337 DOI: 10.1016/j.ejca.2014.08.005].
  • 8李守勉,李明,田罱花,等.不同碳氮源营养划秀珍菇菌丝体生长及其胞外酶活性的影响[J].北方闻艺,2010(1):143-145.
  • 9Merika E, Saif MW, Katz A, et al. Colon cancer vaccines: an up- date [J]. In vivo, 2010, 24:607-628.
  • 10Cunningham D, Atkin W, Lenz H J, et al. Colorectal cancer [ J ]. Lancet, 2010, 375:1030-1047.

引证文献7

二级引证文献40

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部